Status:
COMPLETED
Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
HIV
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will test a therapy for both helping people adhere to their HIV medication regimens and treating them for depression.
Detailed Description
People infected with HIV are more likely to suffer from depression than those not infected, with studies finding anywhere from 20% to 50% of HIV-infected individuals having significant depressive symp...
Eligibility Criteria
Inclusion
- HIV-infected
- Current diagnosis of depression or prescribed an antidepressant medication with at least some residual symptoms (e.g., clinical global impressions \[CGI\] scale score of 2 or greater)
- Prescribed a stable regimen of highly active antiretroviral therapy (HAART) for HIV for at least 2 months
Exclusion
- Active, untreated, and unstable major mental illness (i.e., untreated psychosis or mania) that would interfere with cognitive behavioral therapy (CBT) treatment for depression
- Diagnosis with any primary psychotic disorder, even if treated
- Treatment with CBT within the past year
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00951028
Start Date
September 1 2008
End Date
April 1 2013
Last Update
June 18 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Fenway Community Health Center
Boston, Massachusetts, United States, 02215
3
Butler Hospital
Providence, Rhode Island, United States, 02906
4
The Miriam Hospital
Providence, Rhode Island, United States, 02906